ILLUCCIX

LIVE

Serial Number

79297402

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Aug 27, 2020

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ILLUCCIX Trademark

Serial Number: 79297402 • Registration: 6549629

ILLUCCIX is a trademark filed by Telix Pharmaceuticals Limited on August 27, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Legal Representation

Attorney of Record

Andrew S. Ehard

5,534 trademarks filed View all →

Correspondence Address

Andrew S. Ehard Merchant & Gould P.C.

P.O. Box 2910

[email protected]

Minneapolis, MN 55402

UNITED STATES

Trademark Details

Filing Date

August 27, 2020

Registration Date

November 9, 2021

Published for Opposition

August 24, 2021

Goods & Services

Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use

Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer

Filing History

NEW REPRESENTATIVE AT IB RECEIVED

Feb 26, 2026 NREP

NEW REPRESENTATIVE AT IB RECEIVED

Aug 14, 2022 NREP

FINAL DECISION TRANSACTION PROCESSED BY IB

May 24, 2022 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Apr 29, 2022 FICS

FINAL DISPOSITION PROCESSED

Apr 28, 2022 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Feb 9, 2022 FICR

REGISTERED-PRINCIPAL REGISTER

Nov 9, 2021 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 24, 2021 NPUB

PUBLISHED FOR OPPOSITION

Aug 24, 2021 PUBO

NOTIFICATION PROCESSED BY IB

Aug 22, 2021 GPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Aug 4, 2021 OPNS

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Aug 4, 2021 OP2R

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 4, 2021 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 20, 2021 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 16, 2021 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 16, 2021 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 16, 2021 TROA

REFUSAL PROCESSED BY IB

Feb 7, 2021 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jan 20, 2021 RFCS

REFUSAL PROCESSED BY MPU

Jan 20, 2021 RFRR

APPLICATION FILING RECEIPT MAILED

Jan 5, 2021 MAFR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Dec 31, 2020 RFCR

NON-FINAL ACTION WRITTEN

Dec 30, 2020 CNRT

ASSIGNED TO EXAMINER

Dec 30, 2020 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 30, 2020 NWOS

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Dec 28, 2020 LIMI

SN ASSIGNED FOR SECT 66A APPL FROM IB

Nov 5, 2020 REPR

Related Trademarks

More from this Owner

LUTEON

PTHER-PAN

BIPASS

UROONCRX ONSITE PRECISION RADIOPHARMACY

More in Same Class

Serial #90141894

OLCLY

NEUROSENSE PLANT STEM CELL

COGITARE

RESERVE

RIPPED ROOSTER